-
CHI3L1-IN-5: A Target-Engagement Framework
2026-09-25
CHI3L1-IN-5 (Compound Z17) links CHI3L1 binding to inflammatory signaling and astrocyte function. This article offers an evidence-focused framework for interpreting those findings, designing complementary assays, and recognizing what the data do—and do not—establish.
-
JEV NS4B Disrupts Lysosomal Function Through LAMP Loss
2026-09-25
A 2024 study links Japanese encephalitis virus (JEV) infection to reduced LAMP1 and LAMP2, fewer acidified lysosomes, and impaired lysosomal catabolism. It identifies viral protein NS4B—and amino acids 131–204 in particular—as a driver of ER stress-associated autophagy and lysosomal disruption, providing a mechanistic framework for investigating virus–host effects on lysosomal function.
-
Zoledronic Acid: Cancer and Bone Research Workflows
2026-09-24
Build interpretable Zoledronic Acid experiments by pairing dose–time mapping with orthogonal cell-death readouts and carefully controlled compound preparation. The workflows distinguish cancer-cell effects from bone-disease endpoints, while a psoriasis study offers assay-design lessons—not evidence for a shared mechanism.
-
Q-VD-OPh for Apoptosis Research Workflows
2026-09-24
Q-VD-OPh helps separate caspase-dependent cell death from upstream mitochondrial events, making it useful alongside BAX/BAK imaging and functional viability assays. This guide translates recent pore-imaging findings into practical inhibitor workflows, controls, and troubleshooting strategies.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-09-23
The ECL Chemiluminescent Substrate Detection Kit is a chemiluminescent substrate kit for HRP-based visualization of proteins and nucleic acid targets. Its luminol–hydrogen peroxide reaction supports Western blot chemiluminescence detection and related chemiluminescent immunoassay workflows, including studies of ferroptosis markers.
-
PEI-Laminarin Nanoparticles Boost OVA Immunity
2026-09-23
The reference study developed polyethyleneimine-modified cationic Laminarin nanoparticles that improved ovalbumin delivery, dendritic-cell activation, antigen cross-presentation, and immune responses compared with an aluminum adjuvant. Its main contribution is a structure–function strategy that links polysaccharide functionalization, cellular trafficking, and stronger humoral and cellular immunity.
-
Cycloheximide as a Translation-Apoptosis Probe
2026-09-22
Cycloheximide is more than a routine translation blocker: used deliberately, it can reveal whether apoptotic phenotypes depend on ongoing protein synthesis, protein turnover, or direct mitochondrial execution. This article connects that experimental logic to BAK activation research and provides practical guidance for translational assay design.
-
Lanabecestat: Practical BACE1 Assay Workflows
2026-09-21
Lanabecestat (AZD3293) combines nanomolar BACE1 potency with blood-brain barrier penetration, making it useful for connecting amyloid-beta production inhibition to neuronal-function assays. This guide translates published synaptic-safety findings into practical workflows, exposure controls, and troubleshooting decisions for Alzheimer’s disease research.
-
EZ Cap™ Human PTEN mRNA: Assay Design
2026-09-21
Explore how EZ Cap™ Human PTEN mRNA can anchor mechanism-driven cancer research, from PI3K/Akt pathway restoration to delivery-aware assay design. This article translates recent HA-LNP findings into practical decisions for interpreting PTEN expression and function.
-
mCherry mRNA for LNP Delivery Assay Design
2026-09-20
Use a Cap 1, modified-nucleotide mCherry reporter to separate delivery, translation, and cell-health effects in demanding in vitro workflows. This guide translates the COL7A1 base-editing study into practical LNP benchmarking, reporter assays, and troubleshooting decisions without confusing fluorescence with editing efficacy.
-
EZ Cap™ Mouse IL-7 mRNA: Assay Design Guide
2026-09-19
EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) enables a controlled, traceable IL-7 expression workflow for mechanistic assays. This guide connects its use to APOL1 isoform, haplotype, and protein-interaction questions while clearly separating established evidence from exploratory applications.
-
Isradipine (Dynacirc) Research Workflows
2026-09-19
Isradipine (Dynacirc) provides a practical way to interrogate L-type calcium influx across neuronal, vascular, and hypertension research workflows. This guide connects formulation, calcium-response assays, electrophysiology, and troubleshooting while using channel-selectivity evidence to avoid overinterpreting neuroprotective results.
-
Silybin A: Silymarin Research Reference
2026-09-18
Silybin A is a defined flavonolignan associated with Silymarin and supplied for antioxidant, inflammatory, metabolic, and liver-biology research. Its documented DMSO solubility and storage requirements support controlled in-vitro workflows, while evidence from a praeruptorin A hepatocellular-carcinoma study must not be treated as direct evidence for Silybin A.
-
Beijing M. pneumoniae Resistance in 2023
2026-09-18
A 2024 Beijing study found universal erythromycin and azithromycin resistance among 62 pediatric Mycoplasma pneumoniae isolates, alongside higher azithromycin MICs in 2023 and a uniform A2063G mutation. Its comparison of 16-membered macrolide acetylspiramycin with standard macrolides provides a useful framework for antimicrobial resistance research, while the clinical and molecular data clarify the limits of MIC-based interpretation.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-17
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for poorly water-soluble compounds, particularly molecules with aromatic or phenyl-containing regions. This dossier-based guide supports pharmaceutical and biochemical formulation workflows, but does not establish therapeutic, in vivo, clinical, or bioavailability outcomes.